Product Code: LI_174425 / A04076
The global cell-based assay market was valued $ 11,744 million in 2020 and expected to reach $26,348 million by 2030, with a CAGR of 8.2% from 2021 to 2030.
Cell-based assays are in-vitro assays that are used to examine a variety of cellular characteristics, such as cytotoxicity and cell signaling activation. Cell-based assays and analyses are viable experimental instruments in life sciences research and bio production. The method is based on cell culture procedures, in which living cells are produced in in-vitro and used as model systems for evaluating the biochemistry and physiology of both, healthy and sick cells.
The cell-based assays market is expected to rise in revenue due to technological improvements and widespread use of assays in numerous medicinal applications. Furthermore, a number of major firms are focused on tactics to develop their respective product lines and portfolios, as well as to maintain their market position. Cell-based assays are analytical methods used to investigate a cellular function mechanism or process. Consumables such as reagents, test kits, and microplates, as well as instruments, services, and software, are available from companies creating cell-based assays. Reagents, cell lines, microplates, microplates, assay kits, probes and labels, and other items are included in this report. The high cost of instruments is a major restraint on the global market for cell-based assays. Due to low adaptability, the high cost of the instruments will diminish the return on investment (ROI). Biotek, for example, created HCA (high content analysis) devices, which are costly and only available to industrial end-users or core labs with appropriate capital budgets. The high demand for cell-based tests in drug development and discovery drives the revenue growth of the market. Furthermore, technological advancements in cell-based assays, expanding usage of 3D-based cell assays, and the growing necessity for generating biologically relevant replacements for drug discovery are all contributing to market expansion.
The industry's participants are modifying their long- and short-term growth strategies to capitalize on opportunities in the research market by introducing innovative goods to combat the pandemic. For both, researchers and laboratories, the rise in need for COVID-19 research has provided a wide scope for cell-based 45 tests in viral infection research, vaccine development, and overall drug discovery. A variety of COVID-19 vaccines or antiviral medications have been approved or are in development, and patients are now being treated symptomatically. The functional efficiency of the antibodies produced to neutralize the target virus is assessed for both vaccinations and treatments. Cell-based assays are used to reduce the time and boost the throughput of these experiments.
The cell-based assay market is segmented on the basis of product, application, end user, and geography. On the basis of product, it is categorized into consumable, instrument, service, and software. The consumable segment includes reagents, microplates, probes & labels, assay kits, cell lines, and others. Assay kits are further sub-divided into reporter gene assays, cell growth assays, second messenger assays, cell death assays, and others. Likewise, the cell lines are divided into immortalized cell lines, primary cell lines, and stem cell lines. On the basis of application, the market is divided into drug discovery; basic research; absorption, distribution, metabolism, & excretion (ADME) studies; predictive toxicology; and others.
On the basis of end user, it is categorized into pharmaceutical & biotechnology companies, academic & government research institutes, contract research organizations, and others. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players operating in the global cell-based assay market are Becton, Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific, Inc., General Electric Company, Merck KGaA, Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Lonza Group Ltd., Cell Signaling Technology, Inc., and Promega Corporation.
The other prominent players in the value chain include Macrogen, Inc., New England Biolabs, Inc., Cisbio Bioassays, Cell Biolabs, Inc., and DiscoverX Corporation.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
- A comprehensive analysis of four regions is provided to determine the existing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market
KEY MARKET SEGMENTS
- By Product
- Consumable
- Reagents
- Microplates
- Probes & Labels
- Assay Kits
- Reporter Gene Assays
- Cell Growth Assays
- Second Messenger Assays
- Cell Death Assays
- Others
- Cell Lines
- Immortalized Cell Lines
- Primary Cell Lines
- Stem Cell Lines
- Other Cell Line
- Other Cell Line
- Instrument
- Service
- Software
- By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Government Research Institutes
- Contract Research Organizations
- Others
- By Application
- Drug Discovery
- Basic Research
- ADME Studies
- Predictive Toxicology
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Share Analysis/Top Player Positioning
- 3.4.1. Market Share Analysis/Top Player Positioning 2020
- 3.5. Market Dynamics
- 3.5.1. Drivers
- 3.5.2. Restraints
- 3.5.3. Opportunities
- 3.6. COVID-19 Impact Analysis
CHAPTER 4: CELL BASED ASSAY MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Consumables
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.2.4. Reagents
- 4.2.4.1. Market Size and Forecast
- 4.2.5. Microplates
- 4.2.5.1. Market Size and Forecast
- 4.2.6. Probes and Labels
- 4.2.6.1. Market Size and Forecast
- 4.2.7. Assay Kits
- 4.2.7.1. Market Size and Forecast
- 4.2.8.2. Reporter Gene Assays
- 4.2.8.2.1. Market Size and Forecast
- 4.2.8.2. Cell Growth Assays
- 4.2.8.2.1. Market Size and Forecast
- 4.2.8.2. Second Messenger Assays
- 4.2.8.2.1. Market Size and Forecast
- 4.2.8.2. Cell Death Assays
- 4.2.8.2.1. Market Size and Forecast
- 4.2.8.2. Other Assays
- 4.2.8.2.1. Market Size and Forecast
- 4.2.8. Cell Lines
- 4.2.8.1. Market Size and Forecast
- 4.2.9.2. Immortalized Cell Line
- 4.2.9.2.1. Market Size and Forecast
- 4.2.9.2. Primary Cell Line
- 4.2.9.2.1. Market Size and Forecast
- 4.2.9.2. Stem Cell Line
- 4.2.9.2.1. Market Size and Forecast
- 4.2.9.2. Other Cell Line
- 4.2.9.2.1. Market Size and Forecast
- 4.3. Instruments
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Services
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Softwares
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
CHAPTER 5: CELL BASED ASSAY MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Drug Discovery
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. ADME Studies
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Basic Research
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- 5.5. Predictive Toxicology
- 5.5.1. Key Market Trends, Growth Factors and Opportunities
- 5.5.2. Market Size and Forecast, By Region
- 5.5.3. Market Share Analysis, By Country
- 5.6. Other Applications
- 5.6.1. Key Market Trends, Growth Factors and Opportunities
- 5.6.2. Market Size and Forecast, By Region
- 5.6.3. Market Share Analysis, By Country
CHAPTER 6: CELL BASED ASSAY MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Pharmaceutical And Biotechnology Companies
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Academic And Government Research Institutes
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Contract Research Organizations
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- 6.5. Other End Users
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country
CHAPTER 7: CELL BASED ASSAY MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends, Growth Factors and Opportunities
- 7.2.2. Market Size and Forecast, By Region
- 7.2.3. Market Share Analysis, By Country
- 7.3. Europe
- 7.3.1. Key Market Trends, Growth Factors and Opportunities
- 7.3.2. Market Size and Forecast, By Region
- 7.3.3. Market Share Analysis, By Country
- 7.4. Asia Pacific
- 7.4.1. Key Market Trends, Growth Factors and Opportunities
- 7.4.2. Market Size and Forecast, By Region
- 7.4.3. Market Share Analysis, By Country
- 7.5. LAMEA
- 7.5.1. Key Market Trends, Growth Factors and Opportunities
- 7.5.2. Market Size and Forecast, By Region
- 7.5.3. Market Share Analysis, By Country
CHAPTER 8: CELL BASED ASSAY MARKET, BY REGION
- 8.1. Market Overview
- 8.1.1 Market Size and Forecast, By Region
- 8.2. North America
- 8.2.1. Key Market Trends and Opportunities
- 8.2.2. Market Size and Forecast, By Product
- 8.2.3. Market Size and Forecast, By Application
- 8.2.4. Market Size and Forecast, By End User
- 8.2.5. Market Size and Forecast, By Region
- 8.2.6. Market Size and Forecast, By Country
- 8.2.7. United States Cell Based Assay Market
- 8.2.7.1. Market Size and Forecast, By Product
- 8.2.7.2. Market Size and Forecast, By Application
- 8.2.7.3. Market Size and Forecast, By End User
- 8.2.7.4. Market Size and Forecast, By Region
- 8.2.8. Canada Cell Based Assay Market
- 8.2.8.1. Market Size and Forecast, By Product
- 8.2.8.2. Market Size and Forecast, By Application
- 8.2.8.3. Market Size and Forecast, By End User
- 8.2.8.4. Market Size and Forecast, By Region
- 8.2.9. Mexico Cell Based Assay Market
- 8.2.9.1. Market Size and Forecast, By Product
- 8.2.9.2. Market Size and Forecast, By Application
- 8.2.9.3. Market Size and Forecast, By End User
- 8.2.9.4. Market Size and Forecast, By Region
- 8.3. Europe
- 8.3.1. Key Market Trends and Opportunities
- 8.3.2. Market Size and Forecast, By Product
- 8.3.3. Market Size and Forecast, By Application
- 8.3.4. Market Size and Forecast, By End User
- 8.3.5. Market Size and Forecast, By Region
- 8.3.6. Market Size and Forecast, By Country
- 8.3.7. France Cell Based Assay Market
- 8.3.7.1. Market Size and Forecast, By Product
- 8.3.7.2. Market Size and Forecast, By Application
- 8.3.7.3. Market Size and Forecast, By End User
- 8.3.7.4. Market Size and Forecast, By Region
- 8.3.8. Germany Cell Based Assay Market
- 8.3.8.1. Market Size and Forecast, By Product
- 8.3.8.2. Market Size and Forecast, By Application
- 8.3.8.3. Market Size and Forecast, By End User
- 8.3.8.4. Market Size and Forecast, By Region
- 8.3.9. U.K Cell Based Assay Market
- 8.3.9.1. Market Size and Forecast, By Product
- 8.3.9.2. Market Size and Forecast, By Application
- 8.3.9.3. Market Size and Forecast, By End User
- 8.3.9.4. Market Size and Forecast, By Region
- 8.3.10. Italy Cell Based Assay Market
- 8.3.10.1. Market Size and Forecast, By Product
- 8.3.10.2. Market Size and Forecast, By Application
- 8.3.10.3. Market Size and Forecast, By End User
- 8.3.10.4. Market Size and Forecast, By Region
- 8.3.11. Spain Cell Based Assay Market
- 8.3.11.1. Market Size and Forecast, By Product
- 8.3.11.2. Market Size and Forecast, By Application
- 8.3.11.3. Market Size and Forecast, By End User
- 8.3.11.4. Market Size and Forecast, By Region
- 8.3.12. Rest Of Europe Cell Based Assay Market
- 8.3.12.1. Market Size and Forecast, By Product
- 8.3.12.2. Market Size and Forecast, By Application
- 8.3.12.3. Market Size and Forecast, By End User
- 8.3.12.4. Market Size and Forecast, By Region
- 8.4. Asia-Pacific
- 8.4.1. Key Market Trends and Opportunities
- 8.4.2. Market Size and Forecast, By Product
- 8.4.3. Market Size and Forecast, By Application
- 8.4.4. Market Size and Forecast, By End User
- 8.4.5. Market Size and Forecast, By Region
- 8.4.6. Market Size and Forecast, By Country
- 8.4.7. Japan Cell Based Assay Market
- 8.4.7.1. Market Size and Forecast, By Product
- 8.4.7.2. Market Size and Forecast, By Application
- 8.4.7.3. Market Size and Forecast, By End User
- 8.4.7.4. Market Size and Forecast, By Region
- 8.4.8. China Cell Based Assay Market
- 8.4.8.1. Market Size and Forecast, By Product
- 8.4.8.2. Market Size and Forecast, By Application
- 8.4.8.3. Market Size and Forecast, By End User
- 8.4.8.4. Market Size and Forecast, By Region
- 8.4.9. Australia Cell Based Assay Market
- 8.4.9.1. Market Size and Forecast, By Product
- 8.4.9.2. Market Size and Forecast, By Application
- 8.4.9.3. Market Size and Forecast, By End User
- 8.4.9.4. Market Size and Forecast, By Region
- 8.4.10. India Cell Based Assay Market
- 8.4.10.1. Market Size and Forecast, By Product
- 8.4.10.2. Market Size and Forecast, By Application
- 8.4.10.3. Market Size and Forecast, By End User
- 8.4.10.4. Market Size and Forecast, By Region
- 8.4.11. South Korea Cell Based Assay Market
- 8.4.11.1. Market Size and Forecast, By Product
- 8.4.11.2. Market Size and Forecast, By Application
- 8.4.11.3. Market Size and Forecast, By End User
- 8.4.11.4. Market Size and Forecast, By Region
- 8.4.12. Rest Of Asia-pacific Cell Based Assay Market
- 8.4.12.1. Market Size and Forecast, By Product
- 8.4.12.2. Market Size and Forecast, By Application
- 8.4.12.3. Market Size and Forecast, By End User
- 8.4.12.4. Market Size and Forecast, By Region
- 8.5. LAMEA
- 8.5.1. Key Market Trends and Opportunities
- 8.5.2. Market Size and Forecast, By Product
- 8.5.3. Market Size and Forecast, By Application
- 8.5.4. Market Size and Forecast, By End User
- 8.5.5. Market Size and Forecast, By Region
- 8.5.6. Market Size and Forecast, By Country
- 8.5.7. Brazil Cell Based Assay Market
- 8.5.7.1. Market Size and Forecast, By Product
- 8.5.7.2. Market Size and Forecast, By Application
- 8.5.7.3. Market Size and Forecast, By End User
- 8.5.7.4. Market Size and Forecast, By Region
- 8.5.8. Saudi Arabia Cell Based Assay Market
- 8.5.8.1. Market Size and Forecast, By Product
- 8.5.8.2. Market Size and Forecast, By Application
- 8.5.8.3. Market Size and Forecast, By End User
- 8.5.8.4. Market Size and Forecast, By Region
- 8.5.9. South Africa Cell Based Assay Market
- 8.5.9.1. Market Size and Forecast, By Product
- 8.5.9.2. Market Size and Forecast, By Application
- 8.5.9.3. Market Size and Forecast, By End User
- 8.5.9.4. Market Size and Forecast, By Region
- 8.5.10. Rest of LAMEA Cell Based Assay Market
- 8.5.10.1. Market Size and Forecast, By Product
- 8.5.10.2. Market Size and Forecast, By Application
- 8.5.10.3. Market Size and Forecast, By End User
- 8.5.10.4. Market Size and Forecast, By Region
CHAPTER 9: COMPANY PROFILES
- 9.1. Becton, Dickinson And Company
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Bio-Rad Laboratories
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Cell Signaling Technology
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Danaher Corporation
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. General Electric Company
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Lonza Group
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Merck Kgaa, Darmstadt, Germany
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. PerkinElmer
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Promega
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Thermo Fisher Scientific, Inc.
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments